Astec Lifesciences Ltd
NSE:ASTEC
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
827.75
1 458.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ASTEC stock under the Base Case scenario is 1 041.25 INR. Compared to the current market price of 1 063.05 INR, Astec Lifesciences Ltd is Overvalued by 2%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Astec Lifesciences Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ASTEC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Astec Lifesciences Ltd
Balance Sheet Decomposition
Astec Lifesciences Ltd
Current Assets | 3B |
Cash & Short-Term Investments | 27.9m |
Receivables | 1.3B |
Other Current Assets | 1.7B |
Non-Current Assets | 5.8B |
Long-Term Investments | 53k |
PP&E | 5.2B |
Intangibles | 209.2m |
Other Non-Current Assets | 361.6m |
Current Liabilities | 3.7B |
Accounts Payable | 807.2m |
Other Current Liabilities | 2.9B |
Non-Current Liabilities | 2.2B |
Long-Term Debt | 2.1B |
Other Non-Current Liabilities | 19.1m |
Earnings Waterfall
Astec Lifesciences Ltd
Revenue
|
3.7B
INR
|
Cost of Revenue
|
-3B
INR
|
Gross Profit
|
700m
INR
|
Operating Expenses
|
-1.8B
INR
|
Operating Income
|
-1.1B
INR
|
Other Expenses
|
63.6m
INR
|
Net Income
|
-1B
INR
|
Free Cash Flow Analysis
Astec Lifesciences Ltd
INR | |
Free Cash Flow | INR |
ASTEC Profitability Score
Profitability Due Diligence
Astec Lifesciences Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Astec Lifesciences Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
ASTEC Solvency Score
Solvency Due Diligence
Astec Lifesciences Ltd's solvency score is 34/100. The higher the solvency score, the more solvent the company is.
Score
Astec Lifesciences Ltd's solvency score is 34/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ASTEC Price Targets Summary
Astec Lifesciences Ltd
According to Wall Street analysts, the average 1-year price target for ASTEC is 1 530 INR with a low forecast of 1 515 INR and a high forecast of 1 575 INR.
Dividends
Current shareholder yield for ASTEC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ASTEC Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Astec LifeSciences Ltd. engages in the manufacture and sale of agrochemicals and pharmaceutical intermediates. The company is headquartered in Mumbai, Maharashtra and currently employs 506 full-time employees. The company went IPO on 2009-11-25. The firm operates through the Agrochemicals segment. The company manufactures a range of fungicides, insecticides, herbicides and intermediates for its global customers. The Company’s product and intermediates include triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans and heterocyclic sulfonyl chlorides. The company has two multipurpose production sites at Mahad.
Contact
IPO
Employees
Officers
The intrinsic value of one ASTEC stock under the Base Case scenario is 1 041.25 INR.
Compared to the current market price of 1 063.05 INR, Astec Lifesciences Ltd is Overvalued by 2%.